This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: Microbix Biosystems Inc.
Announces that it is presenting results of its novel Quality Assessment Products and platform technology for supporting the quality management and reproducibility of Molecular Pathology derived diagnoses of infectious diseases at Labquality Days, a lab diagnostics conference taking place in Helsinki, Finland from February 5 to 6. Microbix Biosystems Inc. shares T.MBX are trading down $0.01 at $0.22.
